US Stocks
/
UroGen Pharma Ltd. Share Price
UroGen Pharma Ltd. Share Price

UroGen Pharma Ltd. Share Price

NASDAQ: URGN | Small Cap
$36.82
-$0.24 (-0.65%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

UroGen Pharma Ltd. Stock Performance

Open
$36.88
Prev. Close
$37.06
Circuit Range
N/A
Day Range
$36.77 - $37.99
Year Range
$15.92 - $50.76
Volume
47,521
Average Traded
$37.22

UroGen Pharma Ltd. Share Price Today

As of 11 October 2026, UroGen Pharma Ltd.'s share price is $36.82. The stock opened at $36.88, compared to its previous close of $37.06. During today's trading session, UroGen Pharma Ltd.'s share price traded between $36.77 and $37.99, with an average price of $37.38. Over the past 52 weeks, the stock has recorded a high of $50.76 and a low of $15.92. In terms of performance, UroGen Pharma Ltd.'s share price has risen by 54.45% over the last six months and is up 80.05% on a year-on-year basis.

UroGen Pharma Ltd. Share Price Chart

$36.77$37.99
L
Show Current Price
H

UroGen Pharma Ltd. Stock Fundamentals & Key Indicators

Market Cap
$1.77B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.00
Revenue (TTM)
$109.79B
Return On Equity (TTM)
73.75%
Profit Margin
-139.80%
Debt to Equity
-1.46
Quarterly Earnings Growth YoY
56.97%

UroGen Pharma Ltd. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$27.48$37.84$50.96$72.46
Net Profit-$33.35-$26.36-$23.57-$14.35
Net Profit Margin-121.36%-69.66%-46.25%-19.80%
Income ChangeN/A20.96%10.58%39.12%

UroGen Pharma Ltd. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$64.36$82.71$90.40$109.79
Net Profit-$109.78-$102.24-$126.87-$153.49
Net Profit Margin-170.57%-123.61%-140.34%-139.80%
Income ChangeN/A6.87%-24.09%-20.98%

About UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

UroGen Pharma Ltd. Historical Returns

MonthOpenCloseChange %
Oct 2026
$40.89
$36.83
-9.55%
Sep 2026
$42.98
$40.72
-10.59%
Aug 2026
$37.41
$45.55
+19.29%
Jul 2026
$37.39
$38.18
+3.75%
Jun 2026
$27.70
$36.80
+30.87%
May 2026
$23.93
$28.12
+17.95%
Apr 2026
$18.27
$23.84
+32.59%
Mar 2026
$21.39
$17.98
-17.20%
Feb 2026
$19.42
$21.71
+10.71%
Jan 2026
$23.73
$19.61
-16.48%
Dec 2025
$28.45
$23.48
-18.34%
Nov 2025
$20.29
$28.76
+40.64%

URGN Share Price FAQs

What is UroGen Pharma Ltd. share price today?

chevron-up
UroGen Pharma Ltd. share price today is $36.82 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of UroGen Pharma Ltd. stock?

chevron-up
The 52 week high of UroGen Pharma Ltd. stock is $50.76, while the 52 week low is $15.92 as of 10 Oct '26.

What is URGN's market capitalisation today?

chevron-up
URGN market capitalisation is $1.77B as of October 11, 2026, at 12:26 am IST.

What is URGN's net income for the last quarter?

chevron-up
URGN's net income for the last quarter is -14.35B USD.

What is the 5 year returns of URGN?

chevron-up
The 5 year returns of URGN is 114.07% as on 10 Oct '26.

What is the high & low stock price of URGN today?

chevron-up
URGN stock price hit a high of $37.99 and low of $36.77 as of 10 Oct '26.

Can I buy URGN shares in India?

chevron-up
Yes. You can buy URGN in India by opening an international trading account.